Stockholders’ Equity (Details Narrative) - USD ($)			12 Months Ended
	Feb. 05, 2023	Aug. 11, 2022	Dec. 31, 2024	Dec. 31, 2023	Nov. 27, 2023	Nov. 26, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized			50,000,000	50,000,000	50,000,000	10,000,000
Preferred stock, shares issued			0	0
Preferred stock, shares outstanding			0	0
Common stock, voting right			Holders of common stock are entitled to one vote per share
Common stock, shares authorized			300,000,000	300,000,000
Common stock, par value			$ 0.01	$ 0.01
Common stock, shares issued			15,427,385	4,677,787
Issuing cost paid			$ 1,540,000
Placement Agent Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant issued			20,666
Exercise price			$ 8.25
Warrants contractual term			5 years
Fair value of warrants			$ 21,479
Warrants expired			0
Warrants remaining contractual life			2 years 9 months 10 days
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Principal amount			$ 30,400,000
Accrued Bonuses, Current			$ 42,959
Conversion of Stock, Shares Converted			1,814,627
Public Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Description of public offering	The Public Warrants may be exercised from February 5, 2023 (181 days from the effective date of the Company’s S-1 Registration Statement made effective August 8, 2022, hereafter “Registration Date”) to August 8, 2027 (5 years from the Registration Date). The fair value of the Public Warrants was around $3.28 million and was determined using the Black-Scholes option pricing model with the assumptions: $18.30 of stock price, $21.25 of strike price, 5-year expected term, 277% of expected volatility, 0% of expected dividend rate and 2.97% of risk-free interest rate.	underwriters warrants to purchase up to a total of 7,800 shares of common stock (the “Representative’s Warrants”) pursuant to an underwriting agreement. The Representative’s Warrants are exercisable at $23.375 per share, are initially exercisable 180 days after the effective date of the Offering and have a term of five years from their initial exercise date. The fair value of the Representative’s Warrants was around $107 thousands which was recorded in the additional paid-in capital and was determined using the Black-Scholes option pricing model with the assumptions: $13.75 of stock price, $23.375 of strike price, 5-year expected term, 304% of expected volatility, 0% of expected dividend rate and 2.91% of risk-free interest rate.	public offering (the “Offering”) of an aggregated 780,000 units at a price of $4.25 per unit on August 9, 2022. Each unit issued in the Offering consisted of 0.2 share of common stock and one unit of warrant to purchase 0.2 share of common stock of the Company at a price of $21.25 per share (the “Public Warrants”).
Conversion price per shares			$ 0.01
proceeds from equity			$ 1,170,000,000
Aggregate net proceeds from public offerings			1,780,000
Offering cost			$ 1,540,000
Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Description of public offering			underwriters a 45-day over-allotments option to purchase up to an additional 23,400 shares of common stock and/or up to an additional 117,000 units of Public Warrants at the public offering price. The underwriters exercised its option to purchase an additional 117,000 units of Public Warrants at $0.01 per unit for a total cash proceeds of $1,170. The Company received aggregate net proceeds of approximately $1.78 million after deducting direct offering cost of approximately $1.54 million including underwriting commissions and legal fees.
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized			300,000,000
Common stock, par value			$ 0.01
Common stock, shares issued			247,500
Reserved shares for conversion of convertible notes			8,130,609
Convertible notes shares			2,831,472
Warrants shares issued			1,909,810
ATM reserved			1,855,697
Fair value of special stock bonus			$ 88,996
Common Stock [Member] | At The Market [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
ATM reserved			1,533,630